06618 JD HEALTH
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 3.77X | Oper Margin | 8.4% |
---|---|---|---|
LT Debt/Equity | 0.3% | Net Margin | 7.2% |
Total Debt/Equity | 0.5% | Return on Equity | 7.5% |
Price/Book | 2.63X | Return on Assets | 5.8% |
(HKD 48.300) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 4,426.12 | 2,360.74 | 426.17 | -1,313.01 | -20,453.74 |
---|---|---|---|---|---|
Net Profit Growth (%) | +87.5 | +453.9 | +132.5 | +93.6 | -1,782.7 |
Earnings Per Share (HKD) | 1.408 | 0.756 | 0.137 | -0.424 | -9.261 |
Earnings Per Share Growth (%) | +86.4 | +450.8 | +132.3 | +95.4 | +99.9 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | 34.29 | 63.91 | 352.04 | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 18.364 | 17.061 | 15.789 | 15.258 | 14.629 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-21 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 58,160 | 53,530 | +8.6 | 46,736 |
Operating Result | 4,882 | 2,764 | +76.6 | 792.568 |
Associates | -85.527 | -70.757 | +20.9 | -96.759 |
Profit Before Taxation | 4,797 | 2,693 | +78.1 | 695.809 |
Taxation | 639.662 | 550.468 | +16.2 | 312.58 |
Profit /( Loss) After Taxation | 4,157 | 2,143 | +94.0 | 383.229 |
Minority Interests | -4.83 | 1.039 | -564.9 | 3.124 |
Net Profit | 4,162 | 2,142 | +94.3 | 380.105 |
Earnings Per Share () | 1.4084 | 0.7557 | +86.4 | 0.1372 |
Announcement Date | 2025-03-06 | 2024-03-20 | NA | 2023-03-22 |
* Annualised
Last Update Time: 2025-07-21 21:40:25